IP Library Granted Patent US 9,624,232
Granted Patent B2
US 9,624,232 · App. 14/827,104 · Granted Apr 18, 2017

Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof

Inventors: Joshua Robert Giguere (Sharon, MA); Keith Edward McCarthy (Old Lyme, CT); Helge Alfred Reisch (Westerly, RI); Sergio Sandoval (West Warwick, RI); Jake Larry Stymiest (Foster, RI)
Assignee: Rhodes Technologies
C07D489/08B01J23/42B01J23/44B01J31/1855B01J31/20B01J31/2295B01J31/2414C07C209/00C07C209/44C07C269/04C07D265/30C07D295/03C07D295/205B01J2231/40B01J2531/64B01J2531/821B01J2531/824B01J2531/828B01J2531/847Y02P20/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,624,232
App. No.
14/827,104
Granted
Apr 18, 2017
Kind
B2
Abstract

The present disclosure provides processes for the N-dealkylation of tertiary amines and the use of transition metal catalysts to prepare tertiary N-allyl amine derivatives and secondary amine derivatives thereof. The tertiary amines can be alkaloids and, more particularly, the tertiary amines can be opioids. In specific embodiments, the present disclosure provides methods for use in processes for the synthesis of naloxone and naltrexone from oripavine.

Claims (51)

1. A method for making a compound of Formula (200)

comprising

contacting a compound of Formula (45)

with a compound of Formula (23)

and a base in a first solvent to provide a compound of Formula (211)

 and contacting the compound of Formula (211) with a transition metal catalyst and a second solvent to provide the compound of Formula (200);

wherein:

X is selected from —Cl, —Br, and —I;

R 4 , R 5 , R 6 , and R 7 are each hydrogen;

R 14 and R 16 are each independently selected from —OH, —H, and —OR 17;

R 15 is selected from —OH, —H, —OR 17 , ═O, and ═CH 2 ; and

R 17 is an oxygen protecting group;

V is a leaving group; and

the transition metal catalyst comprises a transition metal selected from the group consisting of Pd[0],Pd[II], Ni[0], and combinations of two or more thereof.

2. The method of claim 1 , wherein V is selected from —Cl, —Br, —I, —OS(O) 2 C 4 F 9 , —OS(O) 2 CF 3 , —OS(O) 2 F, -para-toluene sulfonate, —OS(O) 2 CH 3 , and —B(O(C 1 —C 4 ) alkyl) 2 .

3. The method of claim 1 , wherein the transition metal catalyst comprises a transition metal selected from the group consisting of Pd[0], Pd[II], and combinations thereof.

4. The method of claim 1 , wherein the transition metal catalyst is selected from the group consisting of Pd(PPh 3 ) 4 , Pd(Ph 2 P(CH 2 ) 4 PPh 2 ) 2 , Ni(PPh 3 ) 4 , Ni(Ph 2 P(CH 2 ) 4 PPh 2 ) 2 , [Pd(DBA) 2 ]/PPh 3 , [Pd(OAc) 2 ]/PPh 3 ,[Ni(COD) 2 ]/PPh 3 , NiC1 2 /PPh 3 , Ni[P(OEt) 3 ] 4 , and combinations of two or more thereof.

5. The method of claim 2 , wherein the transition metal catalyst comprises a transition metal selected from the group consisting of Pd[0], Pd[II], and combinations thereof.

6. The method of claim 2 , wherein the transition metal catalyst is selected from the group consisting of Pd(PPh 3 ) 4 , Pd(Ph 2 P(CH 2 ) 4 PPh 2 ) 2 , Ni(PPh 3 ) 4 , Ni(Ph 2 P(CH 2 ) 4 PPh 2 ) 2 ,[Pd(DBA) 2 ]/PPh 3 , [Pd(OAc) 2 ]/PPh 3 , [Ni(COD) 2 ]/PPh 3 , NiCl 2 /PPh 3 , Ni[P(OEt) 3 ] 4 , and combinations of two or more thereof.

7. The method of claim 1 , wherein:

the oxygen protecting group is selected from the group consisting of allyl, benzoyl, benzyl, β-methoxyethoxymethyl, dimethoxytrityl, methoxymethyl, para-methoxybenzyl, methylthiomethyl, pivaloyl, tetrahydropyranyl, trityl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldimethylsilyloxymethyl, tri-iso-propylsilyl, methyl, ethoxyethyl, —C(O)O—CH 2 —CH═CH 2 , tert-butyl-diphenylsilyl, [bis—(4-methoxyphenyl)phenylmethyl)], triphenylmethyl, —C(O)(C 1 —C 4 ) alkyl, —C(O)OR 18 , and —(C 1 —C 6 ) alkyl, each alkyl being unsubstituted or substituted with 1, 2, 3, 4, or 5 independently-selected R 21 groups;

each R 18 is independently selected from —(C 1 —C 6 ) alkyl, —(C 2 —C 6 ) alkenyl, and —(C 2 —C 6 ) alkynyl, each alkyl, alkenyl, and alkynyl being unsubstituted or substituted with 1, 2, 3, 4, or 5 independently-selected R 21 groups; and

each R 21 is independently selected from —Cl, —Br, —I, —NH 2 , —CN, and phenyl.

8. The method of claim 1 , wherein the oxygen protecting group is allyl, benzoyl, benzyl, β-methoxyethoxymethyl, dimethoxytrityl, methoxymethyl, para -methoxybenzyl, methylthiomethyl, pivaloyl, tetrahydropyranyl, trityl, trimethylsilyl, tert-butyldimethylsilyl, tertbutyldimethylsilyloxymethyl, tri-iso-propylsilyl, methyl, ethoxyethyl, or —C(O)O—CH 2 —CH═CH 2 .

9. The method of claim 1 , wherein the first solvent is selected from the group consisting of chloroform, dichloromethane, 1,2-dichloroethane, toluene, tetrahydrofuran, ethyl acetate, acetone, tert-amyl alcohol, tert-butyl alcohol, 3-methyl-3-pentanol, 2,3-dimethyl-3-pentanol, 3-ethyl-pentanol, 2-methyl-2-hexanol, acetonitrile, benzene, carbon tetrachloride, chlorobenzene, 1,2-dichlorobenzene, N,N-dimethylformamide, trifluorotoluene, 1,4-dioxane, 1,2-dimethoxyethane, xylene, and combinations of two or more thereof.

10. The method of claim 1 , wherein the second solvent comprises tert-amyl alcohol, 1,4-dioxane, tetrahydrofuran, or combinations thereof.

11. The method of claim 1 , wherein the base is selected from the group consisting of NaBO 3 , Na 2 HPO 4 , Na 3 PO 4 , K 2 HPO 4 , K 3 PO 4 , NaHCO 3 , KHCO 3 , NaOH, KOH, Na 2 CO 3 , K 2 CO 3 , Cs 2 CO 3 , pyridine, triethylamine, di-iso-propylethylamine, N-methylmorpholine, N,N-dimethylaminopyridine, N-(2-acetamido)-2-aminoethane sulfonic acid, N-(2-acetamido)-iminodiacetic acid, N,N-bis(2-hydroxyethyl)glycine, 3-(cyclohexylamino)-1-propanesulfonic acid, 2-(cyclohexylamino) ethanesulfonic acid, 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid, 4-(2-hydroxyethyl)piperazine-l-ethanesulfonic acid, 2-(4-morpholinyl) ethanesulfonic acid, 4-morpholinepropanesulfonic acid, 1,4-piperazinediethanesulfonic acid, [(2-hydroxy-1,1 -bis(hydroxymethyl) ethyl)amino]-1-propanesulfonic acid, 2-[(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)amino]ethanesulfonic acid, and combinations of two or more thereof.

12. The method of claim 1 , wherein the base is selected from the group consisting of K 3 PO 4 , Na 3 PO 4 , NaHCO 3 , KHCO 3 , Na 2 CO 3 , K 2 CO 3 , Cs 2 CO 3 , triethylamine, di-iso-propylethylamine, and combinations of two or more thereof.

13. The method of claim 2 wherein:

the oxygen protecting group is selected from the group consisting of allyl, benzoyl, benzyl, β-methoxyethoxymethyl, dimethoxytrityl, methoxymethyl, para-methoxybenzyl, methylthiomethyl, pivaloyl, tetrahydropyranyl, trityl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldimethylsilyloxymethyl, tri-iso-propylsilyl, methyl, ethoxyethyl, —C(O)O—CH 2 —CH═CH 2 , tert -butyl-diphenylsilyl, [bis-(4-methoxyphenyl)phenylmethyl)], triphenylmethyl, —C(O)(C 1 —C 4 ) alkyl, —C(O)OR 18 , and —(C 1 —C 6 ) alkyl, each alkyl being unsubstituted or substituted with 1, 2, 3, 4, or 5 independently-selected R 21 groups;

each R 18 is independently selected from —(C 1 -C 6 ) alkyl, —(C 2 -C 6 ) alkenyl, and —(C 2 —C 6 ) alkynyl, each alkyl, alkenyl, and alkynyl being unsubstituted or substituted with 1, 2, 3, 4, or 5 independently-selected R 21 groups; and

each R 21 is independently selected from —Cl, —Br, —I, —NH 2 , —CN, and phenyl.

14. The method of claim 2 , wherein the oxygen protecting group is allyl, benzoyl, benzyl, β-methoxyethoxymethyl, dimethoxytrityl, methoxymethyl, para -methoxybenzyl, methylthiomethyl, pivaloyl, tetrahydropyranyl, trityl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldimethylsilyloxymethyl, tri-iso-propylsilyl, methyl, ethoxyethyl, or —C(O)O—CH 2 —CH═CH 2 .

15. The method of claim 1 , wherein:

R 14 and R 16 are each —OH; and

R 15 is ═O.

16. The method of claim 2 , wherein:

R 14 and R 16 are each —OH; and

R 15 is ═O.

17. The method of claim 1 , wherein the second solvent is selected from the group consisting of chloroform, dichloromethane, 1,2-dichloroethane, toluene, tetrahydrofuran, ethyl acetate, acetone, tert-amyl alcohol, tert-butyl alcohol, 3-methyl-3-pentanol, 2,3-dimethyl-3-pentanol, 3-ethyl-pentanol, 2 methyl-2-hexanol, acetonitrile, benzene, carbon tetrachloride, chlorobenzene, 1,2-dichlorobenzene, N,N-dimethylformamide, trifluorotoluene, 1,4-dioxane, 1,2-dimethoxyethane, xylene, and combinations of two or more thereof.

18. The method of claim 2 , wherein the first solvent is selected from the group consisting of chloroform, dichloromethane, 1,2-dicWoroethane, toluene, tetrahydrofuran, ethyl acetate, acetone, tert-amyl alcohol, text-butyl alcohol, 3-methyl-3-pentanol, 2,3-dimethyl-3-pentanol, 3-ethyl-pentanol, 2-methyl-2-hexanol, acetonitrile, benzene, carbon tetrachloride, chlorobenzene, 1,2-dichlorobenzene, N,N-dimethylformamide, trifluorotoluene, 1,4-dioxane, 1,2-dimethoxyethane, xylene, and combinations of two or more thereof.

19. The method of claim 2 , wherein the second solvent is selected from the group consisting of chloroform, dichloromethane, 1,2-dichloroethane, toluene, tetrahydrofuran, ethyl acetate, acetone, tert-amyl alcohol, tert-butyl alcohol, 3-methyl-3-pentanol, 2,3-dimethyl-3-pentanol, 3-ethyl-pentanol, 2 methyl-2-hexanol, acetonitrile, benzene, carbon tetrachloride, chlorobenzene, 1,2-dichlorobenzene, N,N-dimethylformamide, trifluorotoluene, 1,4-dioxane, 1,2-dimethoxyethane, xylene, and combinations of two or more thereof.

20. The method of claim 2 , wherein the second solvent comprises tert-amyl alcohol, 1,4-dioxane, tetrahydrofuran, or combinations thereof.

21. The method of claim 2 , wherein the base is selected from the group consisting of NaBO 3 , Na 2 HPO 4 , Na 3 PO 4 , K 2 HPO 4 , K 3 PO 4 , NaHCO 3 , KHCO 3 , NaOH, KOH, Na 2 CO 3 , K 2 CO 3 , Cs 2 CO 3 , pyridine, triethylamine, di-iso-propylethylamine, N-methylmorpholine, N,N-dimethylaminopyridine, N-(2-acetamido)-2-aminoethane sulfonic acid, N-(2-acetamido)-iminodiacetic acid, N,N-bis (2-hydroxyethyl)glycine, 3-(cyclohexylamino)-1-propanesulfonic acid, 2-(cyclohexylamino) ethanesulfonic acid, 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid, 4-(2-hydroxyethyl)piperazine-l-ethanesulfonic acid, 2-(4-morpholinyl) ethanesulfonic acid, 4-morpholinepropanesulfonic acid, 1,4-piperazinediethanesulfonic acid, [(2-hydroxy-1,1-bis(hydroxymethyl)ethy)amino]-1-propanesulfonic acid, 2-[(2-hydroxy-1,1-bis(hydroxymethyl)ethy)amino]ethanesulfonic acid, and combinations of two or more thereof.

22. The method of claim 2 , wherein the base is selected from the group consisting of K 3 PO 4 , Na 3 PO 4 , NaHCO 3 , KHCO 3 , Na 2 CO 3 , K 2 CO 3 , Cs 2 CO 3 , triethylamine, di-iso-propylethylamine, and combinations of two or more thereof.

23. The method of claim 1 , wherein X and V are each Cl.

24. The method of claim 2 , wherein X and V are each Cl.

25. The method of claim 3 , wherein X and V are each Cl.

26. The method of claim 4 , wherein X and V are each Cl.

27. The method of claim 15 , wherein X and V are each Cl.

28. The method of claim 16 , wherein X and V are each Cl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2021
From: RHODES TECHNOLOGIES
To: NORAMCO, LLC
Reel/Frame 055627/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2015
From: GIGUERE, JOSHUA R.; MCCARTHY, KEITH E.; REISCH, HELGE A.; SANDOVAL, SERGIO; STYMIEST, JAKE L.
To: PURDUE PHARMA L.P.
Reel/Frame 036960/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2015
From: PURDUE PHARMA L.P.
To: RHODES TECHNOLOGIES
Reel/Frame 036960/0863 →
Continuity (4)
Division 13711520 · Dec 11, 2012
Continuation PCTIB2011001330 · Jun 10, 2011
Provisional Application 61354036 · Jun 11, 2010
Related Publication 20150353568A1 · Dec 10, 2015